Clinical Trial Update: Phase I/II Study of Escalating Doses of Idarubicin Orally Given With Oral Cyclophosphamide, Etoposide, Prednisolone and Intravenous Rituximab in Elderly Patient With Disseminated High Grade Non Hodgkin Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II trial evaluating escalating oral idarubicin with cyclophosphamide, etoposide, prednisolone and intravenous rituximab in elderly patients with dissemi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High-grade Non-hodgkin Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Etoposide (Etoposide)
• Idarubicin (idarubicin)
• Prednisolone (Prednisolone)
• Rituximab (rituximab)

Snippet

Sponsor: Poitiers University Hospital | Conditions: High Grade Lymphomas CD20 Positive | Phase 1, Phase 2 | Status: COMPLETED